# Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

Study · id `cardio:ct-nct04924322` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04924322](<https://clinicaltrials.gov/study/NCT04924322>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04924322

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 258 participants.

## Technical summary

Registry record NCT04924322. Randomized; single masking; primary purpose prevention. Start 2022-05-11 (actual); primary completion 2027-04-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 2/3
- Enrolled: 258 participants (planned count; ClinicalTrials.gov record NCT04924322, source copy `cardio:ctgov-nct04924322-2026-06-08`, retrieved 2026-10-31)
- Started: 2022-05-11 (actual) (ClinicalTrials.gov record NCT04924322, source copy `cardio:ctgov-nct04924322-2026-06-08`, retrieved 2026-10-31)
- Primary completion: 2027-04-30 (anticipated) (ClinicalTrials.gov record NCT04924322, source copy `cardio:ctgov-nct04924322-2026-06-08`, retrieved 2026-10-31)
- Completion: 2027-08-31 (anticipated) (ClinicalTrials.gov record NCT04924322, source copy `cardio:ctgov-nct04924322-2026-06-08`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT04924322, source copy `cardio:ctgov-nct04924322-2026-06-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04924322-2026-06-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- Acronym: CRETE
- Condition: Deep Venous Thrombosis
- Intervention (Drug): Enoxaparin
- Lead sponsor: Yale University
- Lead sponsor class: OTHER
- Collaborator: Children's Hospital Colorado
- Collaborator class: OTHER
- Collaborator: Children's Hospital of Philadelphia
- Collaborator class: OTHER
- Collaborator: BJC HealthCare
- Collaborator class: OTHER
- Collaborator: Medical College of Wisconsin
- Collaborator class: OTHER
- Collaborator: Children's of Alabama
- Collaborator class: OTHER
- Collaborator: Golisano Children's Hospital
- Collaborator class: UNKNOWN
- Collaborator: Maria Fareri Children's Hospital
- Collaborator class: UNKNOWN
- Collaborator: Nationwide Children's Hospital
- Collaborator class: OTHER
- Collaborator: New York Presbyterian Hospital
- Collaborator class: OTHER
- Collaborator: Penn State University
- Collaborator class: OTHER
- Collaborator: University of Iowa
- Collaborator class: OTHER
- Collaborator: Johns Hopkins All Children's Hospital
- Collaborator class: OTHER
- Collaborator: University of Oklahoma
- Collaborator class: OTHER
- Collaborator: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Collaborator class: NIH
- Collaborator: Children's Hospital of Illinois at Peoria
- Collaborator class: UNKNOWN
- Collaborator: Hassenfeld Children's Hospital
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry intervention name matches this record: Enoxaparin (`core:enoxaparin`)
- Registry lists this organization as the lead sponsor: Yale University (`cardio:org-yale-university`)
- Registry lists this organization as a collaborator: Children's Hospital Colorado (`cardio:org-children-s-hospital-colorado`)
- Registry lists this organization as a collaborator: Children's Hospital of Philadelphia (`cardio:org-children-s-hospital-of-philadelphia`)
- Registry lists this organization as a collaborator: Medical College of Wisconsin (`cardio:org-medical-college-of-wisconsin`)
- Registry lists this organization as a collaborator: University of Iowa (`cardio:org-university-of-iowa`)
- Registry lists this organization as a collaborator: University of Oklahoma (`cardio:org-university-of-oklahoma`)
- Registry lists this organization as a collaborator: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (`cardio:org-eunice-kennedy-shriver-national-institute-of-child-health-7cbc9f`)

## Provenance

Content hash: 8a774cb23f0b791f7b209c05495dfc9f64763f38baabf9b9d5d21766b974c826
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
